Australia will get a manufacturing hub for mRNA vaccines as part of a multibillion-dollar agreement with pharmaceutical giant Moderna.
The announcement comes as the country's leading vaccine advisory group is set to hand down its advice on whether a fourth dose will be needed for vulnerable people.
The research and development hub will be based in Victoria at a location yet to be decided, and serve as the headquarters for the company's operations in Australia, Southeast Asia and Oceania.
